The use of biological markers in the diagnosis and follow-up of patients with multiple sclerosis.: Test of the five humours

被引:8
|
作者
Oehninger-Gatti, C [1 ]
Buzó, R [1 ]
Alcántara, JC [1 ]
Chouza, C [1 ]
Gómez, A [1 ]
Cibils, D [1 ]
Gordon-Firing, S [1 ]
机构
[1] Hosp Clin, Neurol Inst, Secc Enfermedades Desmielinizantes, Montevideo, Uruguay
关键词
cerebrospinal fluid; cetrulin rich basic myelin protein of the central nervous system; light chain imbalance; oligoclonal distribution of immunoglobulins multiple sclerosis; soluble interleukin-2 receptor;
D O I
10.33588/rn.3010.99367
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients and methods. We studied five biological fluids which were easily accessible to immunological examination (cerebrospinal fluid, plasma tears, saliva and urine) in 25 patients with multiple sclerosis, clinically definite according to the criteria of Cleveland, Ohio (1991) and tabulated according to the Kurztke's expanded disability status scale. The samples were obtained simultaneously during a clinical bout of the disease before any pharmacological or immunosuppressive treatment had been given. Results. The soluble interleukin-2 levels were significantly raised in at least three of these fluid's -always absent from the urine- when compared with normal controls The sensitivity and specificity of this determination for diagnosis of the condition was greater than that of other immunochemical parameters -oligoclonal distribution of immunoglobulins (specifically of IgG), imbalance of the light Kappa and Lambda chains and physiological studies (evoked potentials). The dosification and quantification of basic myelin protein of the central nervous system, rich in citruline in the urine, may be a parameter of progressiveness. Conclusion. This methodology (five humours test) may be used to establish an earlier more certain diagnosis of multiple sclerosis and also monitor its biological activity together with nuclear magnetic resonance with intravenous contrast.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
  • [41] Quantitative follow-up of patients with multiple sclerosis using MRI: Reproducibility
    Guttmann, CRG
    Kikinis, R
    Anderson, MC
    Jakab, M
    Warfield, SK
    Killiany, RJ
    Weiner, HL
    Jolesz, FA
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1999, 9 (04): : 509 - 518
  • [42] A multi-biomarker follow-up study of patients with multiple sclerosis
    Stilund, Morten
    Gjelstrup, Mikkel Carstensen
    Christensen, Tove
    Moller, Holger Jon
    Petersen, Thor
    BRAIN AND BEHAVIOR, 2016, 6 (09):
  • [43] OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients
    Khalil, Dalia H.
    Said, Mohamed M.
    Abdelhakim, Mohamad Amr Salah Eddin
    Labeeb, Dalia M.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (03) : 315 - 322
  • [44] Immunoreactivity to axonal proteins in multiple sclerosis. A survey from clinical to biological markers
    Maria de los Angeles, Robinson-Agramonte
    Jose Antonio, Cabrera Gomez
    Reiber, Hansotto
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 174 - 174
  • [45] Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate
    Angelsen, A
    Syversen, U
    Stridsberg, M
    Haugen, OA
    Mjolnerod, OK
    Waldum, HL
    PROSTATE, 1997, 31 (02): : 110 - 117
  • [46] Bosentan for digital ulcers in patients with systemic sclerosis. A prospective 3-year follow-up study
    Tsifetaki, Niki
    Botzoris, Vasilios G.
    Argyriou, Evagelia
    Drosos, Alexandros A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S825 - S825
  • [47] Should spinal cord MRI be systematically performed for diagnosis and follow-up of multiple sclerosis? No
    Kremer, S.
    REVUE NEUROLOGIQUE, 2020, 176 (06) : 485 - 486
  • [48] Innovative applications of combined PET/MRI modality in diagnosis and follow-up of Multiple Sclerosis
    Khosravi, Mohsen
    Newberg, Andrew
    Jahangiri, Pegah
    Raynor, William
    Al-zaghal, Abdullah
    Werner, Thomas
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [49] Revised consortium of MS centres MRI protocol for the diagnosis and follow-up of multiple sclerosis
    Traboulsee, A.
    Stone, L.
    Li, D.
    Simon, J.
    Radue, E. W.
    Halper, J.
    O'Connor, P. W.
    Wolinsky, J.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S213 - S213
  • [50] Guidelines for a standardized magnetic resonance imaging protocol for the diagnosis and follow-up of multiple sclerosis
    Li, D
    Traboulsee, A
    Paty, DW
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S76 - S77